Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 379, pseudogene (RNU6-379P) is a non-protein-coding RNA sequence in the human genome classified as a pseudogene. It is derived from the U6 small nuclear RNA family, which, in its functional form, is involved in splicing and snRNP (small nuclear ribonucleoprotein) complexes. As a pseudogene, RNU6-379P has accumulated mutations or disruptions that prevent it from encoding functional RNA, usually making it transcriptionally inactive or non-functional[3][6]. Genome-wide studies classify such pseudogenes as part of the "junk DNA," although recent research suggests some pseudogenes may have regulatory or structural roles in the nucleus or chromatin organization, though no such function has been experimentally validated for RNU6-379P specifically[1][6]. It is not a molecular target for drugs, nor is it directly implicated in disease or used as a biomarker.
None applicable. There are no drugs targeting this pseudogene, so mechanisms of action do not apply[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 379, pseudogene (RNU6-379P).